Last 12 months
Inside the activity.
0 purchase rows · 46 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 15 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 08, 2020 Filed Jul 8, 2020 21:27 UTC |
Stein Steven HEVP & Chief Medical Officer
|
SaleCommon Stock | 610 | $108.56 | $66,221.60 |
DisclosureSEC source: 0001209191-20-041784 · doc4.xml · nonDerivative · entry 6 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,857 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F5 · balance_after: This includes an aggregate of 96,857 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. Read SEC document |
| July 07, 2020 Filed Jul 7, 2020 23:18 UTC |
Hoppenot HerveDirector · Chairman / CEO · President
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 88,406 | $0.00 Strike: $73.21 | $0.00 |
DisclosureSEC source: 0001209191-20-041557 · doc4.xml · derivative · entry 17 Hoppenot Herve · CIK 0001596492 · Director · Chairman / CEO · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 88,406 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Beginning January 8, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Read SEC document |
| July 07, 2020 Filed Jul 7, 2020 23:18 UTC |
Hoppenot HerveDirector · Chairman / CEO · President
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 1,365 | $0.00 Strike: $73.21 | $0.00 |
DisclosureSEC source: 0001209191-20-041557 · doc4.xml · derivative · entry 16 Hoppenot Herve · CIK 0001596492 · Director · Chairman / CEO · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,365 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Beginning January 8, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Read SEC document |
| July 07, 2020 Filed Jul 7, 2020 23:18 UTC |
Hoppenot HerveDirector · Chairman / CEO · President
|
SaleCommon Stock | 88,406 | $110.00 | $9,724,660.00 |
DisclosureSEC source: 0001209191-20-041557 · doc4.xml · nonDerivative · entry 13 Hoppenot Herve · CIK 0001596492 · Director · Chairman / CEO · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,501 F3 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F4 · balance_after: Including the July 2, 2020 Restricted Stock Unit Grant, this includes an aggregate of 118,371 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. Read SEC document |
| July 07, 2020 Filed Jul 7, 2020 23:18 UTC |
Hoppenot HerveDirector · Chairman / CEO · President
|
Exercise / conversionCommon Stock | 88,406 | $73.21 | $6,472,203.26 |
DisclosureSEC source: 0001209191-20-041557 · doc4.xml · nonDerivative · entry 11 Hoppenot Herve · CIK 0001596492 · Director · Chairman / CEO · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2020 Filed Jul 7, 2020 23:18 UTC |
Hoppenot HerveDirector · Chairman / CEO · President
|
SaleCommon Stock | 1,365 | $110.00 | $150,150.00 |
DisclosureSEC source: 0001209191-20-041557 · doc4.xml · nonDerivative · entry 9 Hoppenot Herve · CIK 0001596492 · Director · Chairman / CEO · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,501 F3 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Read SEC document |
| July 07, 2020 Filed Jul 7, 2020 23:18 UTC |
Hoppenot HerveDirector · Chairman / CEO · President
|
Exercise / conversionCommon Stock | 1,365 | $73.21 | $99,931.65 |
DisclosureSEC source: 0001209191-20-041557 · doc4.xml · nonDerivative · entry 7 Hoppenot Herve · CIK 0001596492 · Director · Chairman / CEO · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 21:31 UTC |
Iyengar Vijay KEVP GPS, BD, & Licensing
|
SaleCommon Stock | 3,120 | $107.98 | $336,897.60 |
DisclosureSEC source: 0001209191-20-041787 · doc4.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP GPS, BD, & Licensing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,401 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · price: Represents weighted average sale price. Actual sale prices ranged from $107.04 - $108.74. F3 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 21:27 UTC |
Stein Steven HEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,495 | $0.00 Strike: $88.68 | $0.00 |
DisclosureSEC source: 0001209191-20-041784 · doc4.xml · derivative · entry 8 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,495 shares Expires 2015-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Beginning March 2, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 21:27 UTC |
Stein Steven HEVP & Chief Medical Officer
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 3,381 | $0.00 Strike: $88.68 | $0.00 |
DisclosureSEC source: 0001209191-20-041784 · doc4.xml · derivative · entry 7 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,381 shares Expires 2015-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Beginning March 2, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 21:27 UTC |
Stein Steven HEVP & Chief Medical Officer
|
SaleCommon Stock | 3,283 | $107.99 | $354,531.17 |
DisclosureSEC source: 0001209191-20-041784 · doc4.xml · nonDerivative · entry 5 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,467 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. F4 · price: Represents weighted average sale price. Actual sale prices ranged from $107.04 - $108.79. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 21:27 UTC |
Stein Steven HEVP & Chief Medical Officer
|
SaleCommon Stock | 7,495 | $110.04 | $824,749.80 |
DisclosureSEC source: 0001209191-20-041784 · doc4.xml · nonDerivative · entry 4 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,750 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. F3 · price: Represents weighted average sale price. Actual sale prices ranged from $110.00 - $110.07. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 21:27 UTC |
Stein Steven HEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 7,495 | $88.68 | $664,656.60 |
DisclosureSEC source: 0001209191-20-041784 · doc4.xml · nonDerivative · entry 3 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,245 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 21:27 UTC |
Stein Steven HEVP & Chief Medical Officer
|
SaleCommon Stock | 3,381 | $110.04 | $372,045.24 |
DisclosureSEC source: 0001209191-20-041784 · doc4.xml · nonDerivative · entry 2 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,750 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. F3 · price: Represents weighted average sale price. Actual sale prices ranged from $110.00 - $110.07. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 21:27 UTC |
Stein Steven HEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 3,381 | $88.68 | $299,827.08 |
DisclosureSEC source: 0001209191-20-041784 · doc4.xml · nonDerivative · entry 1 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:30 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,648 | $0.00 Strike: $64.55 | $0.00 |
DisclosureSEC source: 0001209191-20-041572 · doc4.xml · derivative · entry 10 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,648 shares Expires 2021-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Beginning January 21, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:30 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 905 | $0.00 Strike: $64.55 | $0.00 |
DisclosureSEC source: 0001209191-20-041572 · doc4.xml · derivative · entry 9 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 905 shares Expires 2021-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Beginning January 21, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:30 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
SaleCommon Stock | 15,648 | $107.32 | $1,679,343.36 |
DisclosureSEC source: 0001209191-20-041572 · doc4.xml · nonDerivative · entry 7 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,258 F6 · balance_after: Including the July 2, 2020 Restricted Stock Unit Grant, this includes an aggregate of 96,857 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:30 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
Exercise / conversionCommon Stock | 15,648 | $64.55 | $1,010,078.40 |
DisclosureSEC source: 0001209191-20-041572 · doc4.xml · nonDerivative · entry 6 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F4 · price: Represents weighted average sale price. Actual sale prices ranged from $105.66 - $108.48 F5 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:30 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
SaleCommon Stock | 905 | $107.32 | $97,124.60 |
DisclosureSEC source: 0001209191-20-041572 · doc4.xml · nonDerivative · entry 5 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,258 Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:30 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
Exercise / conversionCommon Stock | 905 | $64.55 | $58,417.75 |
DisclosureSEC source: 0001209191-20-041572 · doc4.xml · nonDerivative · entry 4 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,163 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F4 · price: Represents weighted average sale price. Actual sale prices ranged from $105.66 - $108.48 F5 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:30 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
Tax withholdingCommon Stock | 404 | $107.79 | $43,547.16 |
DisclosureSEC source: 0001209191-20-041572 · doc4.xml · nonDerivative · entry 3 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,258 F2 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:27 UTC |
SWAIN PAULA JEVP, Human Resources
|
Tax withholdingCommon Stock | 273 | $107.97 | $29,475.81 |
DisclosureSEC source: 0001209191-20-041568 · doc4.xml · nonDerivative · entry 3 SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,407 F2 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock. F3 · balance_after: Including the July 2, 2020 Restricted Stock Unit Grant, this includes an aggregate of 21,857 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:29 UTC |
Trower PaulPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 104 | $107.79 | $11,210.16 |
DisclosureSEC source: 0001209191-20-041570 · doc4.xml · nonDerivative · entry 3 Trower Paul · CIK 0001642041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,598 F2 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. F3 · balance_after: Including the July 2, 2020 Restricted Stock Unit Grant, this includes an aggregate of 12,628 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:25 UTC |
Stein Steven HEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,437 | $0.00 Strike: $68.62 | $0.00 |
DisclosureSEC source: 0001209191-20-041566 · doc4.xml · derivative · entry 17 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,334 Underlying: Common Stock · 10,437 shares Expires 2028-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:25 UTC |
Stein Steven HEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,437 | $0.00 Strike: $72.27 | $0.00 |
DisclosureSEC source: 0001209191-20-041566 · doc4.xml · derivative · entry 16 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,335 Underlying: Common Stock · 10,437 shares Expires 2029-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2019 and the remainder vesting monthly over three years. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:25 UTC |
Stein Steven HEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,132 | $0.00 Strike: $83.83 | $0.00 |
DisclosureSEC source: 0001209191-20-041566 · doc4.xml · derivative · entry 15 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,194 Underlying: Common Stock · 12,132 shares Expires 2026-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Beginning July 15, 2016, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:25 UTC |
Stein Steven HEVP & Chief Medical Officer
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 596 | $0.00 Strike: $83.83 | $0.00 |
DisclosureSEC source: 0001209191-20-041566 · doc4.xml · derivative · entry 14 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 596 shares Expires 2026-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Beginning July 15, 2016, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:25 UTC |
Stein Steven HEVP & Chief Medical Officer
|
SaleCommon Stock | 10,437 | $107.31 | $1,119,994.47 |
DisclosureSEC source: 0001209191-20-041566 · doc4.xml · nonDerivative · entry 12 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,750 F3 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F4 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. F7 · price: Represents weighted average sale price. Actual sale prices ranged from $105.65 - $108.48 F8 · balance_after: Including the July 2, 2020 Restricted Stock Unit Grant, this includes an aggregate of 96,857 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:25 UTC |
Stein Steven HEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 10,437 | $68.62 | $716,186.94 |
DisclosureSEC source: 0001209191-20-041566 · doc4.xml · nonDerivative · entry 11 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:25 UTC |
Stein Steven HEVP & Chief Medical Officer
|
SaleCommon Stock | 10,437 | $107.31 | $1,119,994.47 |
DisclosureSEC source: 0001209191-20-041566 · doc4.xml · nonDerivative · entry 10 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,750 F3 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F4 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. F7 · price: Represents weighted average sale price. Actual sale prices ranged from $105.65 - $108.48 Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:25 UTC |
Stein Steven HEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 10,437 | $72.27 | $754,281.99 |
DisclosureSEC source: 0001209191-20-041566 · doc4.xml · nonDerivative · entry 9 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:25 UTC |
Stein Steven HEVP & Chief Medical Officer
|
SaleCommon Stock | 12,132 | $107.31 | $1,301,884.92 |
DisclosureSEC source: 0001209191-20-041566 · doc4.xml · nonDerivative · entry 8 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,750 F3 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F4 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. F6 · price: Represents weighted average sale price. Actual sale prices ranged from $105.64 - $108.24. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:25 UTC |
Stein Steven HEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 12,132 | $83.83 | $1,017,025.56 |
DisclosureSEC source: 0001209191-20-041566 · doc4.xml · nonDerivative · entry 7 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:25 UTC |
Stein Steven HEVP & Chief Medical Officer
|
SaleCommon Stock | 596 | $107.31 | $63,956.76 |
DisclosureSEC source: 0001209191-20-041566 · doc4.xml · nonDerivative · entry 6 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,750 F3 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F4 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. F6 · price: Represents weighted average sale price. Actual sale prices ranged from $105.64 - $108.24. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:25 UTC |
Stein Steven HEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 596 | $83.83 | $49,962.68 |
DisclosureSEC source: 0001209191-20-041566 · doc4.xml · nonDerivative · entry 5 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:25 UTC |
Stein Steven HEVP & Chief Medical Officer
|
SaleCommon Stock | 2,522 | $106.40 | $268,340.80 |
DisclosureSEC source: 0001209191-20-041566 · doc4.xml · nonDerivative · entry 4 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,750 F3 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F4 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. F5 · price: Represents weighted average sale price. Actual sale prices ranged from $105.52 - $107.29. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:25 UTC |
Stein Steven HEVP & Chief Medical Officer
|
Tax withholdingCommon Stock | 269 | $107.79 | $28,995.51 |
DisclosureSEC source: 0001209191-20-041566 · doc4.xml · nonDerivative · entry 3 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,272 F2 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:20 UTC |
Iyengar Vijay KEVP GPS, BD, & Licensing
|
Tax withholdingCommon Stock | 404 | $107.79 | $43,547.16 |
DisclosureSEC source: 0001209191-20-041559 · doc4.xml · nonDerivative · entry 3 Iyengar Vijay K · CIK 0001670000 · EVP GPS, BD, & Licensing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,521 F2 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock. F3 · balance_after: Including the July 2, 2020 Restricted Stock Unit Grant, this includes an aggregate of 20,468 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:18 UTC |
Hoppenot HerveDirector · Chairman / CEO · President
|
Tax withholdingCommon Stock | 1,559 | $107.79 | $168,044.61 |
DisclosureSEC source: 0001209191-20-041557 · doc4.xml · nonDerivative · entry 5 Hoppenot Herve · CIK 0001596492 · Director · Chairman / CEO · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,501 F2 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or performance shares previously reported in Table I as common stock. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:15 UTC |
Flannelly Barry PEVP & General Manager US
|
Tax withholdingCommon Stock | 404 | $107.79 | $43,547.16 |
DisclosureSEC source: 0001209191-20-041553 · doc4.xml · nonDerivative · entry 3 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,542 F2 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock. F3 · balance_after: Including the July 2, 2020 Restricted Stock Unit Grant, this includes an aggregate of 33,339 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:13 UTC |
Dhanak DashyantEVP & Chief Scientific Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 961 | $0.00 Strike: $65.42 | $0.00 |
DisclosureSEC source: 0001209191-20-041549 · doc4.xml · derivative · entry 6 Dhanak Dashyant · CIK 0001760682 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,564 Underlying: Common Stock · 961 shares Expires 2028-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:13 UTC |
Dhanak DashyantEVP & Chief Scientific Officer
|
SaleCommon Stock | 961 | $106.58 | $102,423.38 |
DisclosureSEC source: 0001209191-20-041549 · doc4.xml · nonDerivative · entry 4 Dhanak Dashyant · CIK 0001760682 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,591 F3 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F4 · balance_after: Including the July 2, 2020 Restricted Stock Unit Grant, this includes an aggregate of 22,052 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 23:13 UTC |
Dhanak DashyantEVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 961 | $65.42 | $62,868.62 |
DisclosureSEC source: 0001209191-20-041549 · doc4.xml · nonDerivative · entry 3 Dhanak Dashyant · CIK 0001760682 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 23:30 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,743 | $0.00 Strike: $106.47 | $0.00 |
DisclosureSEC source: 0001209191-20-041572 · doc4.xml · derivative · entry 8 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,743 Underlying: Common Stock · 12,743 shares Expires 2030-07-01 F7 · derivative.exercise_date: Beginning July 2, 2020, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 23:30 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
Tax withholdingCommon Stock | 2,187 | $106.47 | $232,849.89 |
DisclosureSEC source: 0001209191-20-041572 · doc4.xml · nonDerivative · entry 2 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,662 F2 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 23:30 UTC |
Wenqing YaoEVP, Head of Discovery Chem
|
GrantCommon Stock | 6,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-041572 · doc4.xml · nonDerivative · entry 1 Wenqing Yao · CIK 0001624033 · EVP, Head of Discovery Chem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,849 F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Wenqing Yao's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 23:27 UTC |
SWAIN PAULA JEVP, Human Resources
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,743 | $0.00 Strike: $106.47 | $0.00 |
DisclosureSEC source: 0001209191-20-041568 · doc4.xml · derivative · entry 4 SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,743 Underlying: Common Stock · 12,743 shares Expires 2030-07-01 F4 · derivative.exercise_date: Beginning July 2, 2020, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 23:27 UTC |
SWAIN PAULA JEVP, Human Resources
|
Tax withholdingCommon Stock | 1,474 | $106.47 | $156,936.78 |
DisclosureSEC source: 0001209191-20-041568 · doc4.xml · nonDerivative · entry 2 SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,680 F2 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 23:27 UTC |
SWAIN PAULA JEVP, Human Resources
|
GrantCommon Stock | 6,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-041568 · doc4.xml · nonDerivative · entry 1 SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,154 F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Paula Swain's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.